journal_search_results

Slogan Text

You searched for articles by ''Witham' in British Journal of Renal Medicine. There are 2 results listed below


Article title:		The impact of a renal supportive care service on symptom control, advance care planning and place of death for patients with advanced chronic kidney disease managed without dialysis
Author name(s):		Claire Douglas, Joanne Sloan, Sarah Cathcart, Louisa Adam, Samira Bell, Lorna Frame, Miles D Witham and Maureen E Lafferty
Journal:		British Journal of Renal Medicine
Issue:		Autumn 2019, Volume 24 Number 3
Pages:		60-65
Intro:		The authors describe how they redesigned their renal supportive care (RSC) service for patients with advanced chronic kidney disease (CKD) managed without dialysis, to enable consultations over a wide geographical area and within the community. The redesigned service includes an RSC nurse, a renal consultant and a palliative medicine consultant. The main components of the service are continuing care of CKD without dialysis, symptom assessment and management, and advance care planning.


Article title:		Acute kidney injury: the business of risk
Author name(s):		Miles D Witham, Helen Hobbs, Christopher K Farmer, Lui G Forni & Andrew J P Lewington.
Journal:		British Journal of Renal Medicine
Issue:		Autumn 2016, Volume 21 Number 3
Pages:		81-85
Intro:		Acute kidney injury (AKI) is a medical emergency that commonly occurs in primary and secondary care. The National Confidential Enquiry into Perioperative Deaths report found that AKI was avoidable in 30% of patients who died from AKI in hospitals. The cost of caring for patients with AKI has been estimated to be £1.02 billion in England. NHS England has prioritised AKI as an area for quality improvement and has positioned AKI in the Patient Safety workstream, establishing the Think Kidneys AKI Programme.

The British Journal of Renal Medicine was previously supported by Baxter Healthcare from 2011 to 2013, by Sandoz in 2011, by Shire Pharmaceuticals from 2006 to 2011, by Ortho Biotech and Shire Pharmaceuticals in 2005, by Ortho Biotech from 2000 to 2005 and by Janssen Cilag from 1996 to 2000.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly, the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title British Journal of Renal Medicine is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2021 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: info@pmlive.com

ISSN 1365-5604 (Print) ISSN 2045-7839 (Online)